Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Malignant Melanoma

Free Subscription 22.12.2025 1 Am J Pathol 2 Ann Surg Oncol 1 BMC Cancer 1 Br J Dermatol 1 Cancer 2 J Am Acad Dermatol 1 J Invest Dermatol 1 PLoS One 2 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Pathol

1. RAO VR, Nguyen V, Phung TL, Sukhadia SS, et al
   Interpreting Deep Learning-based Prediction of BRAF V600E Mutation using Diagnostic Whole Slide Images in Skin Cutaneous Melanoma.
   Am J Pathol. 2025 Dec 12:S0002-9440(25)00435.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

2. ZIJLKER LP, Verwer Z, van der Wiel BA, Kuijpers AMJ, et al
   Independent Dutch Validation Study of CP-GEP (Merlin Assay) for the Prediction of Nodal Metastasis and Long-Term Outcome in Patients with Primary Cutaneous Melanoma.
   Ann Surg Oncol. 2025 Dec 18. doi: 10.1245/s10434-025-18928.
   PubMed         Abstract available
   
   
3. CHAKRABORTY NN, Bhatty M, Zablonski KG, Boone JM, et al
   Is Ultrasound-Based Imaging Essential for Melanoma Active Surveillance?
   Ann Surg Oncol. 2025 Dec 16. doi: 10.1245/s10434-025-18884.
   PubMed         Abstract available
   
   

   
   BMC Cancer

4. GOZE OF, Buettner R, Odenthal M, Heydt C, et al
   Genetic diversity in melanomagenesis: a comprehensive analysis of BRAF, NRAS, KIT and novel mutations across melanoma subtypes.
   BMC Cancer. 2025 Dec 17. doi: 10.1186/s12885-025-15458.
   PubMed         Abstract available
   
   

   
   Br J Dermatol

5. BAIRD J, Murrell D
   P22 Using VECTRA and AI analysis to monitor paediatric lesions: a review of cases.
   Br J Dermatol. 2025;193.
   PubMed         Abstract available
   
   

   
   Cancer

6. 
   Correction to "Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade-resistant melanoma: Final analysis from a phase 1b study".
   Cancer. 2025;131:e70188.
   PubMed        
   
   

   
   J Am Acad Dermatol

7. BANG JS, Kim JY
   Clinical differences between Hutchinson's sign in subungual melanoma and pseudo-Hutchinson's sign in benign longitudinal melanonychia.
   J Am Acad Dermatol. 2025 Oct 25:S0190-9622(25)03087.
   PubMed         Abstract available
   
   
8. TAYLOR MA, Beach L, McGrath J, Shelton E, et al
   Comparable Disease-Specific Survival between Mohs Surgery and Wide Local Excision for Acral Lentiginous Melanoma: A National Cohort Study.
   J Am Acad Dermatol. 2025 Dec 12:S0190-9622(25)03379.
   PubMed        
   
   

   
   J Invest Dermatol

9. LARUE L
   E-Cadherin, MITF, and Phenotypic Plasticity in Melanoma: A Crossroads between Cell Adhesion, Differentiation, and Hormonal Regulation.
   J Invest Dermatol. 2025 Dec 19:S0022-202X(25)03623.
   PubMed        
   
   

   
   PLoS One

10. 
    Retraction: Expression of microRNAs and their target genes in melanomas originating from gynecologic sites.
    PLoS One. 2025;20:e0339074.
    PubMed        
    
    

    
    Proc Natl Acad Sci U S A

11. 
    Correction for AbuHammad et al., Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma.
    Proc Natl Acad Sci U S A. 2025;122:e2533731122.
    PubMed        
    
    
12. FINCK AV, Wang Z, Gonzales D, Wellhausen N, et al
    Dual-targeted ping-pong CAR T cells: Leveraging peripheral expansion to improve solid tumor immunotherapy.
    Proc Natl Acad Sci U S A. 2025;122:e2518996122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.